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Background/Aims
Irritable bowel syndrome (IBS) is a multifactorial disorder, involving dysregulation of brain-gut axis. Our aim was to evaluate the 
neuroendocrine activity in IBS. 
Methods
Thirty IBS and 30 healthy volunteers were enrolled. Psychological symptoms were evaluated by questionnaires. Urinary 
5-hydroxyindoleacetic acid, plasma serotonin (5-hydroxytryptamine, 5-HT), endothelin, and neuropeptide Y (NPY), and plasma and 
urinary cortisol levels were evaluated. Fourteen IBS subjects underwent microneurography to obtain multiunit recordings of efferent 
postganglionic muscle sympathetic nerve activity (MSNA). 
Results
Prevalent psychological symptoms in IBS were maladjustment (60%), trait (40%) and state (17%) anxiety, obsessive compulsive-
disorders (23%), and depressive symptoms (23%). IBS showed increased NPY (31.9 [43.7] vs 14.8 [18.1] pmol/L, P = 0.006), 5-HT 
(214.9 [182.6] vs 141.0 [45.5] pg/mL, P = 0.010), and endothelin [1.1 [1.4] vs 2.1 [8.1] pg/mL, P = 0.054], compared to healthy 
volunteers. Moreover, plasma NPY, endothelin, cortisol and 5-HT, and urinary 5-hydroxyindoleacetic acid were associated with some 
psychological disorders (P ≤ 0.05). Despite a similar resting MSNA, after cold pressor test, IBS showed a blunted increase in MSNA 
burst frequency (+4.1 vs +7.8 bursts/min, P = 0.048; +30.1% vs +78.1%, P = 0.023). Baseline MSNA tended to be associated with 
urinary cortisol (ρ = 0.557, P = 0.059). Moreover, changes in heart rate after mental stress were associated with urinary cortisol (ρ = 
0.682, P = 0.021) and changes in MSNA after mental stress were associated with plasma cortisol (ρ = 0.671, P = 0.024).”
Conclusion
Higher concentrations of endothelin, NPY, and 5-HT were found to be associated with some psychological disorders in IBS patients 
together with an altered cardiovascular autonomic reactivity to acute stressors compared to healthy volunteers.
(J Neurogastroenterol Motil 2017;23:428-434)
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Introduction  
Irritable bowel syndrome (IBS) is the most prevalent functional 
digestive disorder. It negatively affects the quality of life and is as-
sociated with a significant economic burden related to direct and 
indirect annual health-care costs.1 
A recent review shows in the general population a worldwide 
IBS (diagnosed by the Rome III criteria) prevalence of 1.1-29.2%.2 
IBS is characterized by abdominal pain and/or discomfort associ-
ated with a change of shape and/or consistency of stool. The patho-
physiology of IBS is still unclear, but certainly, it involves a dysregu-
lation of the brain-gut axis.3-6 It has been clearly demonstrated that 
IBS patients show an increased reactivity to psychosocial stressors, 
with subsequent hypersensitivity leading to distension and abnormal 
motor pattern of the intestine.3,7 
Approximately 60% of patients with IBS have concomitant 
mood and anxiety disorders; conversely, 75% of patients with major 
depression and panic disorder report some IBS symptoms.8 An 
increased intestinal response to mental stress and clinical response to 
drugs affecting the CNS have been detected in IBS patients,4 sug-
gesting the presence of an alteration in the neuroendocrine pathway. 
Neuropeptide Y (NPY) is a polypeptide present in the central 
and peripheral nervous system and in the digestive tract. In healthy 
volunteers (HVs), there is a positive correlation between serum 
cortisol and NPY, which are used as activation markers of the 
hypothalamic-pituitary-adrenal (HPA) axis and sympathetic fibers 
of autonomic nervous system (ANS) axis, respectively.9,10 NPY can 
also act as a modulator between the ANS and mast cells,11 linking 
the psycho-emotional state to the symptoms of patients with IBS. In 
fact, NPY can modulate the activity of mast cells through specific 
receptors. This activation may lead to a dysregulation of permeabil-
ity and visceral sensitivity of the intestine.4
Another mediator in both the CNS and peripheral tissues is 
serotonin (5-hydroxytryptamine, 5-HT), which acts through its in-
teraction with specific receptors.6 In the gastrointestinal (GI) tract, 
5-HT regulates sensory, secretory, and motor functions through the 
intrinsic and extrinsic nervous system. In particular, in a previous 
study,5 we observed that IBS patients showed a significant associa-
tion between specific psychological characteristics and neuroendo-
crine markers, especially plasma cortisol and NPY. 
For example, endothelin-1 (ET-1) exerts vasoconstrictor and 
mitogenic properties on smooth muscle cells, but has also potent 
effects on GI smooth muscle, leading to contraction of the esopha-
gus, stomach, and small and large intestine.12 Indeed, Nowicki et 
al13 showed that the ET-1 tissue concentration is greater in human 
preterm intestine with histologic evidence of necrotizing enteroco-
litis. Interestingly, ET-1 is able to modulate sympathetic activity in 
humans through type A receptors.14,15 To date, this interaction has 
been demonstrated only in hypertensive patients,15 but we cannot 
exclude the possibility that a greater susceptibility to the sympatho-
excitatory effect of ET-1 might be present in other conditions char-
acterized by autonomic dysregulation, such as IBS. Taken together, 
these data suggest that a dysregulation in sympathetic activity, 
possibly due to neurohormonal alterations, might be implied in the 
pathophysiology of both vascular dysfunction and GI motility dis-
orders. Based on these premises, the objective of this study was to 
assess the neuroendocrine activity in patients with IBS.
Materials and Methods  
Patients
Thirty patients (9 men, 21 women; mean age 38.43 ± 11.82 
years; age range 19-67 years) with IBS according to the Rome III 
criteria7 who were referred to the Gastroenterology outpatients 
services of a single tertiary center in Pisa, Italy, were enrolled in this 
study. Out of 30 IBS patients, 7 patients (2 men and 5 women) had 
mixed diarrhea and constipation; 12 (6 men and 6 women) had 
diarrhea; and 11 (1 man and 10 women) had constipation. We also 
enrolled 30 HVs (14 men, 16 women; mean age 47.79 ± 15.56 
years; age range 27-75 years). The matter of the research was de-
scribed to both the patients and the HVs. The Local Ethics Com-
mittee approved the study. Each study participant delivered written 
informed consent before beginning the study, in accordance with 
the principles of the Declaration of Helsinki (6th Revision, Seoul 
2008). 
Psychological Assessment
The assessment of anxiety, personality dimensions, psycho-
physiological features, fears of the subjects, symptoms of depression, 
obsessions, and compulsions were performed using the question-
naires that were part of the Cognitive Behavioral Assessment (CBA, 
version 2.0).16 
These questionnaires were validated on Italian populations 
of healthy subjects and patients with various diseases. Therefore, 
healthy controls who scored with significant psychological symp-
toms were excluded.
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Neuroendocrine Markers
Venous blood samples of patients and HVs were taken after an 
overnight fasting. As described previously,5 levels of 5-HT, cortisol, 
and NPY were measured in the venous blood samples, and levels 
of cortisol and 5-hydroxyindoleacetic acid (5-HIAA) were also de-
termined in one sample of 24-hour urine excretion from all patients 
and HVs. Endothelin (ELISA; Biomedica Medizinprodukte 
GmbH & Co KG, Vienna, Austria) was measured in the venous 
blood samples.
Microneurography Assessment
Fourteen out of 30 patients (8 men and 6 women) agreed to 
undergo microneurography. 
Microneurography was used to obtain multiunit recordings of 
efferent postganglionic muscle sympathetic nerve activity (MSNA), 
as previously described.15,17 
All experimental sessions were performed in the morning, in a 
quiet and comfortable room. The microelectrodes for the MSNA 
recording and the other measuring devices were positioned. After 
10 minutes, non-invasive beat-to-beat blood pressure (BP) (Por-
tapres; Finapres Medical System, Enschede, The Netherlands), 
heart rate (Biotach; Gould Electronics, Chandler, AZ, USA), and 
MSNA were continuously monitored and recorded, using a digital 
acquisition system (ACQ-16; Gould Electronics) and a dedicated 
computer software (Ponemah; Data Sciences Interntional, New 
Brighton, MN, USA), for a 10-minute interval to obtain baseline 
levels. Then, acute reactivity to stress was evaluated using a mental 
arithmetic stress test and cold pressor test.
During the verbally administered mental arithmetic stress test, 
IBS patients were asked to subtract 2-digit numbers from 4-digit 
numbers as quickly and accurately as possible. Throughout the 
mental arithmetic stress test, the subjects were urged to work more 
quickly and more accurately.18,19 The cold pressor test was per-
formed by immersing the left hand of the subject in ice water up to 
the wrist for 2 minutes.20 MSNA was analyzed by visual inspection 
by a single investigator (R.M.B.). MSNA was quantified as the 
MSNA burst frequency (expressed in bursts/min) and incidence 
(expressed in bursts/100 heart beats). Absolute (D) and relative 
changes from baseline (D%) in MSNA, BP, and heart rate were 
calculated.
Statistical Methods
Statistical analysis was performed using STATA 12 software 
(Stata Statistical Software, College Station, TX, USA). The data 
were not normally distributed, therefore all results were expressed as 
the median and interquartile range. Correlation analysis between 2 
variables was performed using the Spearman rank correlation coef-
ficients (ρ). Comparisons of continuous data were performed using 
the Wilcoxon signed-ranks test applied to two-sample (for compari-
sons between HV and IBS) or to paired samples (for comparisons 
between baseline and acute stressors). Statistical significance was 
assigned to a P-value ≤ 0.05. 
Results  
Psychological Assessment
The most prevalent psychological symptoms in IBS patients 
were: social maladjustment (60%), trait anxiety (40%), obsessive 
compulsive-disorders (23%), depressive symptoms (23%), and 
state anxiety (17%).
Neuroendocrine Markers
Data are summarized in Table 1. Significant differences be-
tween IBS patients and HVs were found in the plasma levels of 
Table 1. Neuroendocrine Markers in the Study Population 
Parameter
Healthy volunteers IBS patients
P-values
Median IQR Median IQR
Neuropeptide Y (pmol/L) 14.8 18.1 31.9 43.7 0.006
Serum cortisol (μg /dL) 15.8 2.9 16.4 9.0 0.718
Urinary cortisol (μg /24 hr) 27.0 27.0 35.2 23.5 0.487
Plasma 5-HT (ng/mL) 141.0 45.5 214.9 182.6 0.012
5-HIAA (mg/24 hr) 9.3 5.9 8.1 4.9 0.468
Endothelin (pg/mL) 1.1 1.4 2.1 8.1 0.054
IQR, interquartile range; 5-HT, 5-hydroxytryptamine (serotonin); 5-HIAA, 5-hydroxyindoleacetic acid.
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neuroendocrine markers. In particular, baseline plasma levels of 
NPY (31.9 [43.7] vs 14.8 [18.1] pmol/L, P = 0.006) and 5-HT 
(214.9 [182.6] vs 141.0 [45.5] pg/mL, P = 0.010) were signifi-
cantly higher in IBS patients than in controls. Plasma endothelin 
showed also a trend to increased values in IBS patients. 
Neuroendocrine Markers and Psychological Features
There were significant associations of NPY with “maladjust-
ment” (P =0.050). Endothelin had a significant association with 
“fears for repellent animals” (P = 0.049) and “fears for natural 
disasters” (P = 0.043). Plasma cortisol had significant associations 
with “obsessive disorders” (P = 0.014),  maladjustment (P < 
0.01), and “fears for repellent animals” (P = 0.04). Plasma 5-HT 
showed significant associations with “state anxiety,” “trait anxiety,” 
and “psychophysical disorders” (P < 0.01). 5-HIAA had a signifi-
cant association with “doubting/ruminating” (P = 0.020). Urinary 
cortisol had significant associations with “trait anxiety” (P = 0.044). 
The associations between neuroendocrine markers and psychologi-
cal features are shown in Table 2.
Neuroendocrine Markers and Microneurography
Hemodynamic and sympathetic variables in IBS patients at 
baseline and after the mental arithmetic stress test and cold pressor 
test are shown in Table 3. In 3 of 14 IBS patients, MSNA record-
ings during the stress tests were not readable because of artifacts 
due to movements and muscle contractions. IBS patients showed 
a significant increase in mean BP and heart rate after both mental 
stress and cold pressor test. Conversely, a significant rise in MSNA 
frequency and incidence was found only after mental stress, thus 
suggesting a blunted response to cold pressor test. Baseline burst 
frequency tended to be positively associated with urinary cortisol 
(ρ = 0.557, P = 0.059). Absolute and relative changes in heart rate 
after mental stress were also positively associated with urinary corti-
sol (D heart rate: ρ = 0.636, P = 0.035; D% heart rate: ρ = 0.682, 
P = 0.021). Absolute and relative changes in burst incidence after 
mental stress were also positively associated with plasma cortisol (D 
MSNA: ρ = 0.551, P = 0.079; D% MSNA: ρ = 0.671, P = 
0.024). Plasma 5-HT tended to be inversely associated with BP 
response to cold pressor test (D mean BP: ρ = –0.582, P = 0.060; 
D% mean BP: ρ = –0.510, P = 0.090). 
Furthermore, we compared individuals with diarrheic IBS sub-
type (n = 6) to the non-diarrheic IBS subtype (defined grouping 
patients with either mixed diarrhea and constipation or constipation 
only): microneurographic parameters at baseline were similar in 
the 2 groups (see Supplementary Table). IBS individuals with non-
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diarrheic subtype had instead a blunted MSNA frequency increase 
after the cold pressor test compared to the diarrheic subtype (median 
value: +0.9 vs +6.7 bursts/min, P = 0.055; +19% vs +42%, P 
= 0.130). Furthermore, individuals with diarrheic subtype tended 
to have a blunted % MSNA incidence increase after mental stress 
compared to non-diarrheic subtype (median value: +19% vs 
+46%, P = 0.090), but a similar absolute change (+3.2 vs +3.5 
bursts/100 hour, P = 0.450).
In order to demonstrate whether the present findings were 
specific of IBS patients, we compared microneurographic features 
of patients enrolled in this study to those of a group of HVs. We se-
lected among HVs participating to previously published studies15,17 
or unpublished protocols a group of 12 age-, sex-, and BP-matched 
individuals (6 men, age 40.7 ± 10.4 years), who performed a simi-
lar microneurographic protocol.
MSNA, mean BP and heart rate in resting conditions, as well 
as their response to mental stress, was similar in IBS individuals and 
in HVs (Table 3). Interestingly, after cold pressor test IBS patients 
had a blunted increase MSNA burst frequency (median value: 
+4.1 vs +7.8 bursts/min, P = 0.048; +30.1% vs +78.1%, P 
= 0.023) and incidence (median value: +3.3 vs +8.1 bursts/100 
heart beats, P = 0.034; 15.1% vs 58.7%, P = 0.023) than HVs, 
while differences in changes in mean BP (median value + 10 vs 
+17 mmHg, P = 0.180; +13.0% vs 22.0%, P = 0.160) and 
heart rate (median value: +4 vs +7 bpm, P = 0.910; +7.0% vs 
+12.0%, P = 0.860) did not reach statistical significance. When 
different IBS subgroups were analyzed, only individuals with a non-
diarrheic IBS subtype had a blunted MSNA frequency increase 
after cold pressor test in comparison to HVs (median value: +0.9 
vs +7.8 bursts/min, P = 0.003).
Discussion  
To our knowledge, this is the first study that evaluated endothe-
lin levels in IBS patients and found increased levels compared with 
HVs. Furthermore, this is the first time that muscle sympathetic 
nerve activity in IBS patients was studied by using direct intraneu-
ral recordings. Although we could not demonstrate any significant 
increase in resting sympathetic activity in IBS patients, autonomic 
reactivity to cold pressor test in the vascular district was blunted, 
particularly in the non-diarrheic IBS subtype. Furthermore, cardio-
vascular autonomic reactivity to mental stress positively correlated 
with cortisol levels, suggesting an association between HPA and 
sympathetic activation in this population. 
The secretion of the glial cell-derived neurotrophic factor, nerve 
growth factor, and transforming growth factor-beta contributes to 
the maintenance of epithelial integrity; the secretion of endothelins 
might be involved in vasoregulation.21 Some studies have demon-
strated an altered autonomic function in IBS patients and suggest 
that IBS patients have increased sympathetic nervous system and 
cardiovascular activation.22,23 The endothelin system seems to exert 
an increased vasoconstrictive and sympathoexcitatory role in con-
ditions characterized cardiovascular risk such as hypertension.15 
Moreover, some studies demonstrated that ET-1 mediates smooth 
muscle contraction in GI tract.12 
According to previous studies,5 NPY levels at baseline are 
higher in IBS patients than in controls. It is possible that NPY 
levels change during psychological distress. In fact, in the present 
Table 3. Hemodynamic and Sympathetic Variables in Irritable Bowel Syndrome Patients at Baseline and After Mental Stress and Cold Pressor 
Test
Baseline Mental stress Cold pressor test
Median IQR Median IQR Median IQR
IBS patients
  Mean BP (mmHg) 79.2 11.6 90.2a 19.8   89.8b 12.3
  Heart rate (bpm) 69.9 16.2 87.0a 29.0   81.5b 33.8
  MSNA burst frequency (bursts/min) 14.9 10.4 18.3a 15.3 19.5 12.0
  MSNA burst incidence (bursts/100 heart beats) 22.6 12.1 23.2a 17.4 27.2   9.5
Healthy volunteers
  Mean BP (mmHg) 84.7 6.5 95.7a 16.7 102.9a 18.1
  Heart rate (bpm) 66.6 10.0 75.0a 23.5   72.8a 18.2
  MSNA burst frequency (bursts/min) 10.3 8.5 15.5a 10.0   19.2a 18.0
  MSNA burst incidence (bursts/100 heart beats) 14.7 14.3 20.2a   5.5   25.5a 28.3
IBS, irritable bowel syndrome; IQR, interquartile range; BP, blood pressure; MSNA, muscle sympathetic nerve activity.
aP < 0.01 vs baseline.
bP < 0.05 vs baseline.
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study, NPY showed a negative association with “maladjustment” 
and plasma cortisol was negatively associated with “fears for repel-
lent animals” and “obsessive-compulsive disorders.” Fear occurs 
in response to a known threat that is external, defined, or otherwise 
non-conflictual in origin; anxiety occurs as a response to a threat 
that is unknown, internal, vague, or conflictual in origin.24
Measurement of plasma NPY levels could play an important 
role in the diagnosis of some functional disorders and their psy-
chological comorbidities that are very frequently present because, 
in most cases, the other neuroendocrine and immune markers 
have only a paracrine effect. In fact, the local release of some neu-
ropeptides into the enteric nervous system could play a role in the 
pathophysiology of IBS, but these neuropeptides cannot be assayed 
in the serum because they spread in a paracrine way. As suggested 
by Forbes et al25 in a mouse model, NPY seems to directly inhibit 
the colonic motor response induced by the corticotrophin-releasing 
factor receptor activation during stress. Given that the local 5-HT 
release in the GI tract is involved in excitatory action on vagal affer-
ent fibers and on contraction of smooth colonic muscle,6 it is pos-
sible that indirect high levels of NPY try to maintain normal colonic 
motor response also during psychological distress, counteracting the 
effect of 5-HT release. Indeed, via the gut-brain axis, local 5-HT 
secretion contributes to central pain perception, visceral hypersensi-
tivity, and transit modification of the GI motility pattern; however, 
several studies demonstrated alterations in plasma 5-HT in a spe-
cific subgroup of IBS patients but not in all IBS patients.5,6,26 
In this study, the mean levels of plasma cortisol were not sig-
nificantly different between IBS patients and controls, suggesting 
an uncoupling between the HPA and ANS axes. Our data are 
consistent with a previous study by Fukudo et al27 that observed 
increased plasma levels of adrenocorticotropic hormone but normal 
levels of cortisol in response to corticotropin releasing hormone 
injection in IBS patients. However, our results suggest a more com-
plex relationship between the HPA and ANS axes in IBS, with a 
facilitator role of the HPA axis on ANS that manifests only during 
conditions of acute stress. Indeed, baseline cortisol levels, a possible 
index of distress in this population, are associated with an increased 
cardiovascular autonomic reactivity to stress, as represented by the 
increase of MSNA during mental challenge. This result is in line 
with previous findings showing that in humans, injection of cor-
ticotropin increases MSNA,28 while a correlation between resting 
MSNA and morning salivary cortisol has been observed in healthy 
young individuals.29 Finally, a preliminary analysis according to IBS 
subtypes suggest that a blunted response to the cold pressor test 
is present in the non-diarrheic subtype. A hypo-reactivity of sym-
pathetic central integration and/or sympathetic efferent pathways 
might reflect a generalized hyporesponsiveness of the ANS to stim-
uli, possibly underlying the clinical feature of IBS in this subgroup. 
It is important to outline the methodological limitations of the 
study. First, IBS patients had, as expected, a significantly higher 
prevalence of psychological disorders in comparison to HVs. 
Therefore, it is not possible to demonstrate whether the altered neu-
roendocrine pattern shown in IBS is disease-specific or it is rather 
related to the psychological comorbidity. Furthermore, the control 
group for MSNA substudy was not recruited on purpose for this 
study, adding another possible source of bias, and had a small 
sample size; for this reason, MSNA results should be considered 
preliminary and interpreted with caution. It is mandatory that these 
aspects should be investigated in further studies with adequate sam-
ple size and appropriately selected control group in order to confirm 
the findings of this pilot study.
In conclusion, this study demonstrated for the first time that 
endothelin levels are increased in IBS patients compared to con-
trols, suggesting a possible involvement of endothelin in autonomic 
disorders present in IBS patients. Furthermore, circulating levels 
of cortisol are related to autonomic cardiovascular reactivity to 
stress in this population, thus establishing a new link between the 
ANS and HPA axes in IBS pathophysiology. Though our study 
failed to demonstrate an altered sympathetic traffic directed to the 
vasculature, a blunted sympathetic response to cold pressor test was 
shown, particularly in the non-diarrheic subtypes, suggesting that 
multiple autonomic dysregulations might be present in this condi-
tion. Finally, higher concentrations of NPY were demonstrated in 
IBS patients than in controls. If this relationship is confirmed in a 
larger sample of IBS patients, the use of this neuropeptide could be 
considered as a possible diagnostic marker for IBS or could at least 
help to detect possible IBS psychological comorbidities. 
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